Colonic targeting of aminosalicylates for the treatment of ulcerative colitis
- 30 June 2005
- journal article
- review article
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 37 (6), 381-388
- https://doi.org/10.1016/j.dld.2004.12.011
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Monitoring activity in ulcerative colitisAlimentary Pharmacology & Therapeutics, 2002
- Ulcerative colitisThe Lancet, 2002
- Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic AcidClinical Pharmacokinetics, 1985
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.Gut, 1980
- Is Plasma Level Monitoring of Sulfasalazine Indicated in the Treatment of Crohnʼs Disease or Ulcerative Colitis?Therapeutic Drug Monitoring, 1980
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator PhenotypeNew England Journal of Medicine, 1973
- Salazopyrin, a new sulfanilamide preparation. A. Therapeutic Results in Rheumatic Polyarthritis. B. Therapeutic Results in Ulcerative Colitis. C. Toxic Manifestations in Treatment with Sulfanilamide Preparations.Acta Medica Scandinavica, 1942